Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
93.8K
-
Shares change
-
+71.7K
-
Total reported value, excl. options
-
$353K
-
Value change
-
+$270K
-
Number of buys
-
2
-
Price
-
$3.76
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q4 2023
2 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q4 2023.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.8K shares
of 74.9M outstanding shares and own 0.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.51M shares), NOMURA HOLDINGS INC (2.95M shares), VANGUARD GROUP INC (2.83M shares), Elliott Investment Management L.P. (1.55M shares), GEODE CAPITAL MANAGEMENT, LLC (1.16M shares), STATE STREET CORP (1.07M shares), MARSHALL WACE, LLP (463K shares), NORTHERN TRUST CORP (449K shares), MILLENNIUM MANAGEMENT LLC (288K shares), and MORGAN STANLEY (251K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.